Zobrazeno 1 - 10
of 18
pro vyhledávání: '"U. M. Zanger"'
Publikováno v:
The Pharmacogenomics Journal. 3:335-342
The present study investigated the effect of cytochrome P450 2C9 (CYP2C9) genetic polymorphism on the biotransformation of valproic acid (VPA) to its hepatotoxic metabolite, 4-ene-VPA, and compared that to the formation of the inactive 4-OH-VPA and 5
Publikováno v:
Xenobiotica. 26:107-116
1. Epoxide hydrolases form an enzyme family involved in the metabolism of a variety of xenobiotics including cytostatic drugs and carcinogens. Whether human microsomal epoxide hydrolase--one of the main members of the epoxide hydrolase family--is exp
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 136(10)
Pharmacogenomics follows the concept of individualized medicine via targeted and tailored therapy for each patient. This is aided by current progress in human genome research that provided the basis to link genetic markers with pathogenesis and progr
Publikováno v:
Journal of Biological Chemistry. 268:3952-3963
Pituitary-derived trophic hormones regulate cell-type-specific expression of VL30 retrotransposons in tissues that are engaged in steroidogenesis. We show that adrenocorticotropic hormone and forskolin induced VL30 transcription in the steroidogenic
Publikováno v:
Journal of Biological Chemistry. 265:17197-17201
A cDNA coding for an allelic variant of rat IID1, designated IID1v, was isolated that produced a P-450 having a 10-fold lower catalytic activity toward the substrate bufuralol when expressed in COS-1 cells (Matsunaga, E., Zanger, U. M., Hardwick, J.
Autor:
A. Telenti, U. M. Zanger
Publikováno v:
Annual review of pharmacology and toxicology. 48
Pharmacogenetics holds promise in HIV treatment because of the complexity and potential toxicity of multidrug therapies that are prescribed for long periods. Thus far, few candidate genes have been examined for a limited number of allelic variants, b
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 2
Publikováno v:
The Histochemical journal. 33(6)
Microsomal epoxide hydrolase is a biotransformation enzyme which is involved in the hydrolysis of various epoxides and epoxide intermediates. In the present study, its distribution was investigated in both normal human tissues and human tumours of di
Autor:
T, Lang, K, Klein, J, Fischer, A K, Nüssler, P, Neuhaus, U, Hofmann, M, Eichelbaum, M, Schwab, U M, Zanger
Publikováno v:
Pharmacogenetics. 11(5)
The human cytochrome P450, CYP2B6, is involved in the metabolism of several therapeutically important drugs and environmental or abused toxicants. In this study, we present the first systematic investigation of genetic polymorphism in the CYP2B6 gene
Autor:
R, Eiselt, T L, Domanski, A, Zibat, R, Mueller, E, Presecan-Siedel, E, Hustert, U M, Zanger, J, Brockmoller, H P, Klenk, U A, Meyer, K K, Khan, Y A, He, J R, Halpert, L, Wojnowski
Publikováno v:
Pharmacogenetics. 11(5)
The genetic component of the inter-individual variability in CYP3A4 activity has been estimated to be between 60% and 90%, but the underlying genetic factors remain largely unknown. A study of 213 Middle and Western European DNA samples resulted in t